Position in ELAN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$407,418
+$90,226 QoQ
Shares Held
16,555
+24.9% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#302
of 515 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ELAN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Rafferty Asset Management, LLC holds $21,876,011 across 22 Drug Manufacturers - Specialty & Generic names. ELAN ranks #8 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
48,590 | $3,491,677 | |
| 2 | ALKS |
Alkermes plc.
|
62,965 | $3,299,366 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
18,743 | $3,158,945 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
5,742 | $3,111,187 | |
| 5 | BCRX |
Biocryst Pharmaceuticals Inc
|
265,618 | $2,656,180 | |
| 6 | VTRS |
Viatris Inc
|
140,790 | $2,235,745 | |
| 7 | IRWD |
Ironwood Pharmaceuticals Inc
|
152,878 | $643,616 | |
| 8 | ELAN |
Elanco Animal Health Inc
This page
|
16,555 | $407,418 |
All Filings in ELAN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $407,418 | 16,555 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $317,192 | 13,255 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $437,347 | 19,326 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $410,493 | 20,382 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $237,833 | 16,655 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $329,427 | 31,374 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $342,894 | 28,315 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $445,400 | 30,320 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $322,741 | 22,366 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $502,010 | 30,836 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $476,770 | 31,998 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $356,678 | 31,733 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $356,616 | 35,449 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $258,819 | 27,534 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $285,703 | 23,380 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $203,126 | 16,368 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $208,941 | 10,644 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $430,067 | 16,484 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $878,871 | 30,968 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $732,130 | 22,958 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $518,233 | 14,939 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $328,750 | 11,163 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $517,678 | 16,879 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $390,684 | 13,988 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $298,390 | 13,911 | Shares | Sole | 2020-08-07 | |
| No filing history on record for this holder in this stock. | ||||||